Back to Search
RAYMOND HADDAD, M.D.
M.D.
Internal Medicine Physician
NPI: 1881775427Individual
Specialties, Licenses & Credentials
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
0101021198(VA)
Research & Publications (20)
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
PMID 19634161·Cancer·2009
3-trial
Multidisciplinary approach to cancer treatment: focus on head and neck cancer.
PMID 18154862·Dent Clin North Am·2008
6-review
HPV16 transmission between a couple with HPV-related head and neck cancer.
PMID 18061523·Oral Oncol·2008
5-case
Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer.
PMID 16548781·Expert Opin Ther Targets·2006
7-preclinical
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
PMID 16785415·Arch Otolaryngol Head Neck Surg·2006
8-other
Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer.
PMID 15685044·Am J Clin Oncol·2005
5-case
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.
PMID 12907212·Oral Oncol·2003
3-trial
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer.
PMID 12827298·Cancer Chemother Pharmacol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 E MARSHALL ST, DEPT. OF INTERNAL MEDICINE/ENDOCRINOLOGY
RICHMOND, VA 23298 - Phone
- (804) 828-2161
Quick Facts
- NPI
- 1881775427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile